Annabelle is a PhD student at the Kirby Institute, UNSW Sydney and is the Manager of the Hepatitis Policy Unit at NSW Health. Annabelle is passionate about using research to inform policies and improve healthcare access and outcomes.

Natasha Martin is a Professor in the Division of Infectious Diseases and Global Public Health, University of Califórnia San Diego. She holds a joint honorary professorship at University of Bristol.

Ms Ogechi is a senior programme officer with National Agency for the Control of AIDS with over 10 years working experience in HIV and Key population programmes including PWIDS.

A Clinical Research Fellow in Hepatology with experience in clinical trials, community screening, outreach testing, outpatient management, and enhancing linkage to care for vulnerable populations.

Morgan is a National Point of Care Testing (POCT) practitioner in the Wales Specialist Virology Centre (WSVC), Public Health Wales. She has been in her POCT role since June 2022, having joined WSVC in 2020 where she worked on routine viral testing; Dried Blood Spot Test in particular.

Andy Seaman (he/they) is an Associate Professor of Medicine at Oregon Health & Science University, the Medical Director of Hepatitis and HIV Services at Portland, Oregon's Central City Concern. He is boarded in addiction medicine. His research centers on the intersection of hepatitis C and injection drug use.

James O'Grady is a Research Coordinator with the Métropoles sans Hépatite C initiative in Montreal, Canada. He specializes in qualitative research and works closely with affected communities to ensure lived experiences inform program design and policy for hepatitis C elimination.

Mr. Kibugu David Clinical Officer at MSF Switzerland Kenya Mission, Mombasa Project. Experienced Clinical officer demonstrated achievements working in the non-profit organization industry. Skilled in Health Promotion, HIV care and treatment/prevention, Healthcare Management, MAT Clinic support, and Community Health Initiatives.

Camila is a multidisciplinary public health researcher with experience in health systems responses, particularly to viral hepatitis among difficult to reach populations such as migrants and people who use drugs. Camila is particularly interested in identifying opportunities to improve care for chronic conditions among vulnerable populations through community-based interventions.

Maka Gogia is Programs director at GHRN. Having a high medical education and Master degree in Public health she has extensive experience in program management and research. She has long advocacy experience in increasing accessibility to HIV/HCV/TB/STI treatment and prevention services for key affected population.